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Abstract
Aging is characterized by progressive memory decline that can lead to dementia when associated with neurodegeneration. Here,
we show in mice that aging-related memory decline involves defective biogenesis of microRNAs (miRNAs), in particular miR-
183/96/182 cluster, resulting from increased protein phosphatase 1 (PP1) and altered receptor SMAD (R-SMAD) signaling.
Correction of the defect by miR-183/96/182 overexpression in hippocampus or by environmental enrichment that normalizes
PP1 activity restores memory in aged animals. Regulation of miR-183/96/182 biogenesis is shown to involve the
neurodegeneration-related RNA-binding proteins TDP-43 and FUS. Similar alterations in miR-183/96/182, PP1, and R-
SMADs are observed in the brains of patients with amyotrophic lateral sclerosis (ALS) or frontotemporal lobar degeneration
(FTLD), two neurodegenerative diseases with pathological aggregation of TDP-43. Overall, these results identify new mecha-
nistic links between miR-183/96/182, PP1, TDP-43, and FUS in age-related memory deficits and their reversal.
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Introduction
Aging is often associated with a progressive deterioration of
learning abilities, attention and memory formation [3]. These
deficits vary in their manifestation and severity, ranging from
occasional lapses in memory to widespread deficits in multi-
ple cognitive domains. Longitudinal studies of brain function-
ing in the elderly have revealed progressive deficits especially
in episodic long-term memory [14]. Further, marked memory
impairment together with other neuropsychiatric symptoms,
collectively called dementia, is a cardinal feature of aging-
associated neurodegenerative disorders. Animal models of
such disorders have deficits in memory prior to any obvious
indication of neuronal death, implicating mechanisms inde-
pendent of neurodegeneration [11, 39]. Consistently, an epi-
genetic mechanism ofmemory deficit was recently reported in
a mouse model of Alzheimer disease (AD, [13]).
Alterations in multiple signaling pathways, particularly
pathways related to neuronal plasticity and synaptic functions
have been implicated in age-related cognitive decline.
MicroRNAs (miRNAs) are potential important players in the
mechanisms underlying memory loss associated with aging
and neurodegeneration [23]. Comparison of deep sequencing
data from whole brain in young and aged mice have shown
differential expression of 93 miRNAs with aging [18].
Similarly, proteins pathologically aggregated in neurodegener-
ative disorders, such as TAR DNA-binding protein of 43 kDa
(TDP-43) and fused in sarcoma (FUS), regulate the activity of
miRNAs biogenesis machinery, in particular Drosha and Dicer
[9, 20]. Impaired miRNA biogenesis is therefore an important
candidate mechanism for cognitive dysfunction in neurodegen-
erative disorders with TDP-43 and FUS pathologies.
We previously showed that the nuclear biogenesis of the
miRNAs cluster miR-183/96/182, a cluster upregulated in the
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adult brain by learning, is regulated by the memory suppressor
protein phosphatase 1 (PP1) in a transcription-independent
manner [42].As pathological protein aggregates in neurode-
generative disorders are often phosphorylated, for instance,
TDP-43 aggregates in amyotrophic lateral sclerosis (ALS)
and frontotemporal lobar degeneration (FTLD, [31]), FUS
aggregates in FTLD [32], and tau aggregates in FTLD and
other tauopathies [40], an alteration of phosphatases has been
proposed to be implicated in these disorders. Further, TDP-43
and FUS also regulate the expression or activity of some phos-
phatases [33, 38]). Thus, a role for PP1 in the regulation of
memory-related miRNAs and an implication of phosphatases
in neurodegenerative disorders suggest that abnormal PP1 ac-
tivity leading to impaired biogenesis of memory-related
miRNAs could contribute to memory impairment in neurode-
generative conditions.
Here, we demonstrate that in the aged brain, increased nu-
clear PP1 impairs the biogenesis of miR-183/96/182 that cor-
relates with memory decline. Correction of this impairment by
reduction in PP1 activity or miR-183/96/182 increase in the
hippocampus restore memory functions. We also show that
PP1 is increased and miR-183/96/182 decreased in the brain
of ALS and FTLD patients postmortem. Finally, we show
that TDP-43 and FUS regulate the biogenesis of miR-183/
96/182 (in a PP1-dependent manner for TDP-43), and involve
receptor SMAD proteins (R-SMADs) as likely mediators of
the interaction between miR-183/96/182 and PP1.
Materials and Methods
Animals
Young (3months old) and aged (18months old) C57Bl/6 mice
were purchased from Janvier (France). The mice were group-
housed (four per cage) under a reverse 12-h light/dark cycle
(25 °C, 55% humidity) with food and water ad libitum.
Behavioral experiments were conducted during the dark cy-
cle. Experiments and animal maintenance were conducted in
compliance with the Federation of Swiss Cantonal Veterinary
Office and approved by Zürich Cantonal Veterinary Office
(54/2012).
Novel Object Recognition (NOR) Task
Object recognition training was conducted in a rectangular
arena (60 cm × 50 cm × 45 cm), with gray, opaque walls,
and a translucent plexiglass bottom with an infrared light
source placed below. The box was located in a dedicated be-
havioral room illuminated by a dim light. Before NOR train-
ing, each animal was handled daily for 4 min on 4 consecutive
days. This was followed by an open field test, which involved
placing each mouse in the empty arena for 10 min and
measuring overall locomotor activity. An additional habitua-
tion to the empty arena was conducted one day before the
NOR training. For training (acquisition), three different unfa-
miliar objects were placed in the center of the arena in a trian-
gular arrangement. Each animal was allowed to explore the
objects for a 10-min session. Object memory was tested in 5-
min sessions for which one of the familiar objects was re-
placed with a novel object at 24 h (test 1) and 48 h (test 2)
after training. The time each animal spent exploring each ob-
ject during testing was measured with a video tracking system
(View Point Behavior Technology) by an experimenter
blinded to group assignment. Object memory was expressed
as the proportion of time spent exploring the novel object
compared to the time spent exploring all objects (discrimina-
tion index). The discrimination index was normalized taking
the average value from control animals as 100%. The animal
movements were tracked by an infrared camera connected to a
tracking software (View Point Behavior Technology). For
miRNA expression experiments, NOR controls (identified as
Bhabituation^) were subjected to identical procedures without
an exposure to objects.
Environmental Enrichment (EE)
Young adult (4–5 months) and aged (19–21 months) C57Bl/
6J male mice were either housed in standard cages or in envi-
ronmentally enriched cages for 4 weeks. Standard housing
consisted of a clear polycarbonate standard Aero cages
(391 × 199 × 160 mm) containing wood chip bedding and
nesting material. Enriched housing consisted of a clear poly-
carbonate type 2000P cage (610 × 435 × 215 mm) containing
wood chip bedding, nesting material, two running wheels, a
climbing ladder, a jungle gym, a plumbing pipe, multiple
plastic balls, a rubber ball, and a wooden stick.
Cell Culture
Mouse neuroblastoma (N2A) cells were obtained from
American Type Cell Culture Collection (ATCC) and cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM, high glu-
cose), supplemented with 10% (v/v) FBS (Gibco®) and 1%
Antibiotic-Antimycotic (Gibco®). These cells were chosen
for their fast growth, easy maintenance and transfection, and
potential for neuronal differentiation making them a conve-
nient model for studying miRNA biogenesis. The cells were
proven free of mycoplasma contamination through regular
tests. Before the start of experiments, the cells were passaged
1:4 and split every 3 days for at least five passages. On trans-
fection day, 150,000–300,000 cells were plated in 6- or 12-
well plates. Transfection of a pool of siRNAs targeting TDP-
43/FUS/α-synuclein (Flexitube siRNA, Qiagen) or negative
control siRNA (All Star negative control, Qiagen) was carried
out with HiPerfect® transfection reagent (Qiagen).
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Overexpression or inhibition of nuclear PP1 was achieved by
expressing plasmids containing PP1γ or NIPP1 open read
frame (Origene). Then the cells were returned to the incubator
after transfection and grown for 48 h prior to harvest or further
treatment. The cells were harvested by removing the medium,
washing with ice-cold PBS three times, and lysing with Tri-
reagent® (for RNA extraction) or RIPA buffer (for protein
extraction) or 0.05% Trypsin-EDTA (for sub-cellular fraction-
ation). All experiments were conducted on at least three rep-
licates from different passage number, and repeated at least
three times.
Drug Treatments
Cellular senescence was induced by treating N2a cells with 8
or 16 mM hydroxyurea (HU, Sigma-Aldrich, St. Louis, MO,
USA) for an incubation time (37 °C, 5% CO2) of 12 h. HU
treatment was done 12 h prior to cell lysis. H2O was used as a
control. Induction of cellular senescence was confirmed by
checking the expression of senescence markers p21 and p53.
Primer sequences: p21 (Fwd: TACTTCCTCTGCCC
TGCTGC, Rev: GCTGGTCTGCCTCCGTTTT), p53 (Fwd:
CACGTACTCTCCTCCCCTCAAT, Rev: AACTGCAC
AGGGCACGTCTT). Protein phosphatases were inhibited
by treating N2a cells with okadaic acid (cell signaling) at
two different doses: 20 nM (inhibition of PP1/PP2A) and
0.1 nM (inhibition of PP2A only) [19].
Nuclear PP1 Activity Assays
Nuclear PP1 activity assays were performed as previously
described [22]. Briefly, hippocampi were dissected and ho-
mogenized in 500 ul of cytoplasmic extraction buffer
(Subcellular Protein Fractionation Kit for Tissue, Thermo
Fischer scientific), transferred to Pierce Tissue Strainer and
centrifuged at 500 g for 5 min. The supernatant containing
the cytoplasmic protein fraction was isolated, and the pellet
containing the nuclear fraction was incubated on ice for
10 min, and centrifuged at 3000 g for 5 min in 325 ul mem-
brane extraction buffer. The pellet containing the nuclei was
resuspended in 110 ul of nuclear extraction buffer (NEB),
incubated for 30 min, and centrifuged at 5000g for 5 min.
The supernatant containing soluble nuclear extracts was
desalted using PiBind resin (Innova Biosciences).
Phosphatase activity was determined by incubating 20 ul of
the isolated nuclear fraction with 0.75 mM RII phosphopep-
tide substrate (BIOMOL), with or without 5 nM tautomycin
(selective inhibitor of PP1 at 5 nM, ENZO Life Sciences) at
30 °C for 10 min. The amount of free phosphate released was
measured with BIOMOL green reagent (BIOMOL) at 620 nm
and background subtracted. Nuclear PP1 activity was calcu-
lated by subtracting the nuclear phosphatase activity with
tautomycin from the nuclear phosphatase activity without
tautomycin.
Luciferase-Based Pri-miRNA Processing
Pri-miRNA processing assays were conducted as previously
described [4, 5]. Briefly, fragments of pri-mir-182 and pri-mir-
183 containing the hairpin and 100 bp flanking sequence were
amplified from genomic DNA. The PCR products were
digested with the respective restriction enzymes and inserted
at MCS in pmirGLO vector (Dual Reporter Luciferase Assay
System, Promega) downstream to firefly luciferase reporter.
Cropping of the hairpin stem-loop of the inserts results in
destabilization of the firefly reporter leading to a decrease in
firefly luminescence. The unperturbed renilla reporter pro-
duces stable luminescence, which serves as internal normali-
zation control. Dual-luciferase reporters with pri-mir-182 and
pri-mir-183 were transfected in N2a cells using cationic lipo-
somes (Lipofectamine 2000 reagent, Invitrogen). The cells
were lysed 48 h post-transfection with passive lysis buffer
(Promega) treatment at room temperature for 10 min. The
lysates were then transferred to a 96-well plate, and luciferase
activities of firefly and renilla were read through luminometer
GloMax 96 (Promega) equipped with dual injections dispers-
ing LAR II (for firefly luciferase quantification) and Glomax
(for renilla luciferase quantification) reagents sequentially.
Plasmid Production for miRNA Overexpression
The scAAV2-EF1a-pri-miR-183/96/182-GFP construct was
produced by cutting scAAV2-MCS (Cell Biolabs) by BalI/
NotI (New England Biolabs). The transgene cassette contain-
ing Ef1a promoter (sequence from pEGP-mmu-miR-182 plas-
mid; Cell Biolabs), engineered truncated (T)-pri-miR-183/96/
182, EGFP (from pEGP-mmu-miR-182 plasmid; Cell
Biolabs), WPRE motif and 5′-BalI and 3′-NotI adapters was
chemically synthesized by GENEWIZ (South Plainfield,
USA) and cloned into the scAAV backbone. Sequence of T-
p r i - m i R - 1 8 3 / 9 6 / 1 8 2 i s a s f o l l o w s : 5 ′
cctctgcagggtctgcaggctggagagtgtgactcctgtcctgtgtatggcactggta-
gaattcactgtgaacagtctcagtcagtgaattaccgaagggccataaacagagcag-
agacagatccgcgagcaccttggagctcctcacccctttctgcctagacctctgtttcc-
aggggtgccagggtacaaagacctcctctgctccttccccagagggcctgttccagt-
accatctgcttggccgattttggcactagcacatttttgcttgtgtctctccgctgtgagc-
aatcatgtgtagtgccaatatgggaaaagcgggctgctgcggccacgttcacctccc-
ccggcatcccataataaaaacaagtatgctggaggcctcccaccatttttggcaatgg-
tagaactcacaccggtaaggtaatgggacccggtggttctagacttgccaactatggt-
gtaagtgctgagct. The scAAV2-EF1a-pri-miR-183/96/182-GFP
allowed the generation of mature miR-183-5p, miR-96-5p,
and miR-182-5p sequences annotated in miRBASE v.20
(www.mirbase.org), whose expression was verified both by
RT-qPCR and Northern blot analysis in HEK293 cells
transfected with scAAV2-EF1a-pri-miR-183/96/182-GFP
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plasmid (data not shown). We also verified that expression of
these miRNAs in HEK293 cells leads to specific repression of
reporter mRNAs bearing miR-183/96/182 sites (data not
shown). Control scAAV2-EF1a-control-GFP construct
contained fragment of beta-globin intron (sequence from
pEGP-mmu-miR-182 plasmid; Cell Biolabs) of length corre-
sponding to T-pri-miR-183/96/182.
scAAV Production
Self-complementary AAV production was performed by triple
transfection of HEK 293Tcells using polyethylenimine with a
plasmid bearing the target sequences between the internal ter-
minal repeats of scAAV2, the AAV-helper plasmid encoding
Rep2 and Cap for serotype 8, and the pHGTI-Adeno1 plasmid
harboring helper adenoviral genes (both kindly provided by C
Cepko, Harvard Medical School, Boston, MA, USA). Vectors
were purified using a discontinuous iodixanol gradient
(Sigma, Optiprep). Encapsidated DNA was quantified by
TaqMan RT-PCR following denaturation of the AAV particles
by Proteinase K, and titers were calculated as genome copies
(GC) per milliliter.
Stereotaxic Surgery and Intra-Hippocampal Injections
To overexpress miRNAs, virus vectors were prepared as de-
scribed above. The oligonucleotides were stereotaxically
injected into the CA1 region of the hippocampus at a concen-
tration of 1μg/ul, in TurboFect in vivo transfection reagent
(Dharmacon). Animals were anesthetized with 3% isoflurane
(Attane) and placed in a stereotaxic frame. Anesthesia was
maintained with 1.5% isoflurane in 100% oxygen throughout
surgery. Injection was carried out by lowering a glass pipette
(Blaubrand, cut to a 20-μm inner diameter) filled with virus/
oligonucleotides and attached to an injection pump (Stoelting)
through a predrilled hole at the following coordinate targeting
CA1 region of the hippocampus (from Bregma): AP −
2.0 mm, ML ± 1.5 mm, DV − 1.6 mm. A total of 1 μl
(109GC/ml) of virus vector or 1.5 μl of TSB oligos was
injected into each hippocampus at a rate of 0.2 μl/min. The
glass pipette was left in place for an additional 5 min, before it
was carefully withdrawn and the wound was closed. The an-
imals were allowed to recover for 14 days in their home cage
before behavioral testing.
RNA Extraction and RT-qPCR
Mouse hippocampal tissue was homogenized using TissueLyser
(Qiagen) in Trizol reagent (Invitrogen). Total RNAwas extracted
by phenol-chloroform precipitation. For extraction from cells, the
mediumwas removed, the cells were washed three timeswith ice
cold-PBS, lysed and homogenized by adding Trizol directly to
the plates. Subcellular fractionation of nuclear and cytoplasmic
RNA was performed using Norgen’s Cytoplasmic and nuclear
RNA purification kit (Norge BioTek, Canada). One microgram
of total RNAwas treated with RNase-free DNase (Promega) and
reverse transcribed using miScript II RT kit (Qiagen). Miscript
primer assays (Qiagen) for mature and precursor miRNAs were
used to amplify the respective transcripts from a cDNA pool. For
mRNAquantification, Quantitect (Qiagen) gene-specific primers
were used. Real-time PCR was performed on LightCycler 480®
(Roche). Small nuclear RNA (RNU6) or GAPDH was used as
endogenous control and quantification was performed as previ-
ously described [37].
Protein Extraction and Western Blotting
Total proteins were extracted from N2a cells using radio immu-
noprecipitation buffer (RIPA) with 1:1000 protease inhibitor
cocktail (Sigma-Aldrich) and 1:500 phenyl methyl sulfonyl fluo-
ride (PMSF). Cells were lysed directly on the culture plate with
100–150 □l RIPA and scraped off with a cell scraper. The lysate
was transferred to a micro centrifuge tube and sonicated for five
cycles, each comprising 30- s of sonication with 30-s intervals.
The resulting mixture was centrifuged for 15 min at 14,000g to
separate the protein mixture (supernatant) from cellular debris
(pellet). Nuclear proteins were extracted from N2a cells as de-
scribed in the section BPP1 activity assays.^ Twenty- to forty-
microgram proteins were resolved on SDS-PAGE and trans-
ferred onto a nitrocellulose membrane (Bio-rad). Membranes
were blocked in 3% BSA for 1 hour, and then incubated in
primary (overnight at 4 °C) and secondary (1 hour at room tem-
perature) antibodies. They were scanned using Odessey IR scan-
ner (Li-Cor Bioscience), and band intensity was determined and
quantified using image analysis software (ImageJ). The follow-
ing antibodies were used: primary anti-phospho SMAD 1/5 Ser
463/465 (Cell Signaling Technology, mAb 9516), Drosha
(Abcam, ab135956), DGCR8 (Abcam, ab35865), Cyclophilin
A (Abcam, ab58144), Histone H3 (Abcam, ab 1791), GAPDH
(Abcam, ab 9485); secondary—anti-mouse IRDye® goat anti-
mouse (LI-COR, 925-32210), and IRDye® goat anti-rabbit (LI-
COR, 925-32211).
Human Tissue
Fresh frontal cortices from controls (n= 6-8), sALS (n = 10), and
FTLD (n=9-12) brains were fixed with phosphate-buffered
3.65% formaldehyde, embedded in paraffin, cut into 6-μm serial
sections and mounted on glass slides. Sections were
deparaffinated and rehydrated using a gradient of alcohol.
Antigen retrieval was done by boiling the sections in 10-mM
ci t r a t e bu f f e r (pH 6 .0 ) i n a mic rowave oven .
Immunohistochemistry was performed using the avidin-biotin
complex (ABC) detection system (Vector Laboratories) and
3,3-diaminobenzidine. Endogenous peroxidases were first
quenched with 5% H2O2 in methanol for 30 min, and sections
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were blocked in 0.1 mol/L Tris with 2% fetal bovine serum for
5 min. Primary antibodies were incubated for 2 h at room tem-
perature. The following primary antibodies were used: affinity-
purified rabbit polyclonal anti-TDP-43 (pan TDP-43 pAb
1:4000; ProteinTech), and phosphorylation specific rabbit poly-
clonal pAb anti-pTDP (pS403/404 1:2000 Cosmobio). After
washing, sections were sequentially incubated with biotinylated
secondary antibodies for 1 h and avidin-biotin complex for 1 h.
Bound antibody complexes were visualized by incubating sec-
tions in a solution containing 100 mM Tris, pH 7.6, 0.1% Triton
X-100, 1.4 mM diaminobenzidine, 10 mM imidazole, and
8.8 mM H2O2. Sections were then lightly counterstained with
h ema t o x y l i n , d e h y d r a t e d , a n d c o v e r s l i p p e d .
Immunofluorescence (IF) analysis was performed using
phosphorylation-specific rabbit polyclonal pAb anti-pTDP pri-
mary antibody (pS403/404 1:1000 Cosmobio), Alexa Fluor
488—conjugated secondary antibody (Life Technologies), and
treatment for autofluorescence with Sudan Black 0.2% w/v in
70% ethanol before mounting with ProLong Antifade—DAPI
mountant (Life Technologies) and coverslipping. Digital images
were obtained using Life Technologies EVOS FL Auto imaging
system (Life Technologies).
Statistical Analyses
To confirm discrimination of novel object by the animals during
memory testing against a predefined chance level, one-sample
Student’s t test was used. For behavioral/molecular data compar-
ison between two groups, unpaired Student’s t test was used,with
additional Welsch correction in cases where the variances were
unequal between the two groups. For data involving comparison
between more than two groups, one-way ANOVAwas used. To
check the effect of aging on miRNA upregulation upon learning,
two-way ANOVAwas employed. Significant ANOVA analyses
were followed by post-hoc pair-wise comparisons. Tukey’s or
Sidak’s post-hoc was used for pair-wise comparisons. Outliers
were defined as values beyond two standard deviations from the
group mean and were removed from the analyses. Significance
was set at p < 0.05 for all tests and two-sided tests were per-
formed. Statistical analysiswas performed usingGraphPad prism
version 7 and verified by SPSS version 23. All graphs were
drawn with GraphPad prism version 7.
Results
MiR-183/96/182 Is Decreased with Aging in theMouse
Hippocampus while Nuclear PP1 Activity Is Increased
To assess the role of miR-183/96/182 and PP1 in age-related
cognitive decline, we trained young (4–5 months) and old (20–
21 months) mice on a novel object recognition (NOR) task
(Supplementary Fig. 1). We chose NOR because it depends on
the hippocampus, is an efficient and reliable paradigm to induce
long-term memory, and can reveal cognitive deficits associated
with aging [34, 42]. Agedmice had impairedmemory for objects
compared to young mice when tested 24 and 48 h after training
(Fig. 1a). In youngmice, memory formation was associated with
an increase in miR-183 and 182 and their precursor (pre-mir-183
and pre-miR-182) and primary (pri-mir-183-96-182) RNAs in
the hippocampus 30 min after NOR training, but not in aged
mice where only pri-mir-183-96-182 was increased (Fig. 1b, c).
Since PP1 can regulate miR-183/96/182 biogenesis post-tran-
scriptionally, we examined if the failure in miR-183/182 upreg-
ulation after NOR training is linked to changes in the level of PP1
[42]. Consistently, nuclear PP1 activity was significantly in-
creased in the hippocampus of aged mice (Fig. 1d), while one
of its inhibitors, the regulatory subunit PP1R1A, was decreased
and its nuclear localization partner AKAP1 increased
(Supplementary Fig. 2).
Increase in Nuclear PP1 Activity with Aging Impairs
Microprocessor-Mediated Biogenesis
of miR-183/96/182 Through R-SMADs
We next tested if the microprocessor processing of pri-mir-183/
96/182 is affected by the increased nuclear PP1 or aging using
renilla-firefly dual-reporter assays for pri-mir-183 and pri-mir-
182 processing in mouse neuroblastoma (N2a) cells [2, 42].
Induction of senescence by hydroxyurea treatment
(Supplementary Fig. 3) and PP1 overexpression decreased the
microprocessor processing of pri-mir-183 (Supplementary
Fig. 4) [10]. Overexpression of PP1 did not alter the expression
of Drosha/DGCR8, two major components of the microproces-
sor complex (Supplementary Fig. 5), suggesting that they are not
directly involved in the effect of PP1.
Since pri-mir-183-96-182 has a SMAD-binding element
(SBE) and R-SMADs depend on phosphorylation at serine
463/465 for nuclear localization and interaction with the mi-
croprocessor component p68 [6, 7], we examined if R-
SMADs are altered. Overexpression of a nuclear inhibitor of
PP1 (NIPP1) increased R-SMAD 1/5 Ser463/465 phosphory-
lation in N2a cells (Supplementary Fig. 6), suggesting that
nuclear PP1 can regulate the microprocessor processing of
miR-183/96/182 by dephosphory la t ing SMADs.
Consistently, pharmacological inhibition of transforming
growth factor beta (TGF-β)known to lead to R-SMADs phos-
phorylation, decreased pre-mir-183 (Supplementary Fig. 7).
Further, microprocessor processing of pri-mir-183 decreased
when SMAD5 was knocked-down (Supplementary Fig. 8).
Overexpression of miR-183/96/182 in Hippocampus
Reverses Age-Related Cognitive Deficits in Aged Mice
To assess the causal relationship between miR-183/96/182
and memory decline, we overexpressed miR-183/96/182 in
Mol Neurobiol
area CA1 of the hippocampus in aged mice using a self-
complementary adeno-associated virus (scAAV) vector ex-
pressing pre-miR-183/96/182 fused to GFP. Injected aged
mice had memory performance comparable to young mice
when tested 24 and 48 h after NOR training (Fig. 2a), suggest-
ing that miR-183/96/182 can correct aged-related cognitive
decline. Further, when exposed to environmental enrichment
(EE), a paradigm known to reverse cognitive impairment in
aged animals, nuclear PP1 activity was decreased while the
expression of its inhibitors PP1R1A and NIPP1 was increased
(Fig. 2b, c). EE also increased miR-183/182 and their precur-
sors (Fig. 2d), confirming that this cluster can be dynamically
regulated by memory-enhancing paradigms.
TDP-43 and FUS Regulate miR-183/96/182 Biogenesis
Emerging evidence suggests that changes in the expression and
functions of miRNAs are associated with memory deficits in
neurodegenerative disorders. This may result from altered ex-
pression of memory-relevant genes, in the case of early and
subtle memory impairment, and possibly subsequent induction
of genes favoring neuronal death [16, 43]. We examined if im-
paired biogenesis of miR-183/96/182 contributes to cognitive
dysfunction associated with neurodegeneration using pri-mir-
183/182 assays in vitro. Knock-down of TDP-43, a protein im-
plicated in ALS and FTLD, impaired the microprocessor pro-
cessing of pri-mir-183 and pri-mir-182 (Fig. 3a). This effect was
in part rescued by pharmacological inhibition of PP1 (Fig. 3b).
TDP-43 knock-down also increased nuclear PP1 activity (Fig.
3c) but did not change the expression of Drosha or DGCR8
(Supplementary Fig. 9), suggesting that TDP-43 is implicated
in the regulation of miR-183/96/182 and PP1. Interestingly,
knock-down of FUS, another RNA-binding protein implicated
in ALS and FTLD, also impaired the microprocessor processing
of pri-mir-183 and pri-mir-182 (Fig. 3d), suggesting that both
TDP-43 and FUS can regulate miR-183/96/182 biogenesis. A
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Fig. 1 Effects of aging on object memory and miR-183/182 expression. a
Performance of young and aged mice was tested 24 and 48 h after novel
object recognition (NOR) training and expressed as discrimination index.
At both 24 and 48 h, only young animals demonstrate significant discrim-
ination of the novel object (chance level set at 33.3%) (24 h—one-sample
t test, control 33.3%, p < 0.05; 48 h—one-sample t test, control 33.3%, p
< 0.05). Additionally, young mice discriminate novel object better than
aged mice at 48 h (unpaired t test *p < 0.05). Young, n = 9 and aged, n =
8. bYoung and agedmice were trained on an NOR task and hippocampus
was collected 30 min after the end of training. NOR training increases
miR-183 (left) and 182 (right) in young, but not aged mice (two-way
ANOVA: miR-183: F 1, 17 = 3.399, p = 0.0021, post-hoc: young **p <
0.01, aged p = 0.618, miR-182: F 1, 17 = 11.04, p = 0.004, post-hoc:
young **p < 0.01, aged p = 0.978). Young, n = 6 and aged, n = 6. c
NOR training increases pre-mir-182 (left panel) in young but not aged
mice, but increases pri-mir-183/96/182 in both young and aged mice
(right panel) (two-way ANOVA: pre-mir-183: F 1, 15 = 1.555, p = 0.23,
post-hoc: young p = 0.15, aged p = 0.99; pre-mir-182: F 1, 15 = 5.908,
p = 0.028, post-hoc: young *p < 0.05, aged p = 0.99; pri-mir-183/96/
182: F 1, 15 = 22.42, p = 0.0006, post-hoc: young **p < 0.01, aged #p
< 0.1). Young, n = 6 and aged, n = 6. d Nuclear PP1 activity is increased
in hippocampus from aged mice compared to youngmice (unpaired t test:
*p < 0.05). Aged, n = 4 and young, n = 4
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reduction in this miRNA cluster could therefore be a common
mechanism underlyingmemory impairment in TDP-43 and FUS
pathologies. To further confirm that FUS regulates miR-183/96/
182, we checked the expression of miR-183/96/182 in FUS
knock-in mice. MiR-183 and miR-96 expression was lower but
miR-182 was normal in the cortex of FUS knock-in mice
(Supplementary Fig. 10). Importantly, knock-down of alpha-
synuclein (α-synuclein), another neurodegeneration-related pro-
tein, did not impair the microprocessor processing of pri-mir-183
or pri-mir-182, pointing to the specificity of miR-183/96/182
regulation by TDP-43 and FUS (Supplementary Fig. 11).
MiR-183/96/182 and PP1 Are Implicated in Human
ALS and FTLD
We then explored the relevance of these findings for humans
and focused on patients with ALS and FTLD, neurodegener-
ative conditions characterized by TDP-43 pathological aggre-
gation (Fig. 4a) and cognitive dysfunctions [31, 36].
Consistent with our observation in aged mice, miR-183/96/
182 expression was decreased in frontal cortex of patients
with ALS while PP1γ, a predominantly nuclear isoform of
PP1 was increased (Fig. 4b, c). MiR-183/96/182 expression
was similarly decreased in the cortex of patients with FTLD
with a comparable increase in PP1γ (Fig. 5a, b). Further,
expression of several target genes of the cluster, known to be
implicated in synaptic functions and cognitive processes, and
previously shown to be affected by miR-183/96/182 expres-
sion [42], was increased in both ALS (Fig. 4d) and FTLD
(Fig. 5c) patients, suggesting that reduced miR-183/96/182
expression in these disorders likely has functional conse-
quences. Similar to data in vitro, R-SMADs appear as inter-
mediates of the interaction between increased PP1 and de-
creased miR-183/96/182 in human subjects with TDP-43 pa-
thology, since phospho-SMAD 1/5 showed a trend (p = 0.06)
towards decrease in cortex from ALS and FTLD patients with
TDP-43 pathology compared to age-matched controls (Fig.
5d).
Fig. 2 Effects of miR-183/96/182 overexpression and EE on age-related
memory deficits. a Overexpression of miR-183/182 in the hippocampus
reverses memory decline in aged mice. Young mice have significant
discrimination of the novel object at both 24 and 48 h (24 h: one-
sample t test, control 33.3%, p < 0.1; 48 h: one-sample t test, control
33.3%, p < 0.05). miRNA-injected aged mice have significant discrimi-
nation of the novel object at 48 h (one-sample t test, control 33.3%, p <
0.01). MiRNA-injected aged mice show increased discrimination for the
novel object when compared to vehicle-injected aged mice at 48 h (one-
way ANOVA, F 2, 14 = 6.018, p = 0.01, post-hoc: young *p < 0.05, miR-
183/96/182 injected aged *p < 0.05). Young, n = 4, vehicle-injected aged,
n = 8, and miR-183/96/182 injected aged, n = 8. bNuclear PP1 activity is
significantly decreased in the hippocampus of aged mice exposed to EE
(aged EE) compared to standard-housed agedmice (Aged SH) (unpaired t
test, *p < 0.05). Aged SH, n = 8 and aged EE, n = 8. c Increased mRNA
expression of PP1R1A and NIPP1 in hippocampus from aged mice ex-
posed to 4 weeks of EE compared to standard-house aged mice (unpaired
t test: PP1R1A: *p < 0.05, NIPP1: #p < 0.1). Aged SH, n = 8 and aged EE,
n = 8. d Increased expression of miR-183 and miR-182, and their precur-
sors in hippocampus from aged EE mice compared to aged mice in stan-
dard housing (unpaired t test: miR-183: #p < 0.1; miR-182: *p < 0.05;
pre-mir-183: #p < 0.1; pre-mir-182: *p < 0.05). Aged SH, n = 6 and aged
EE, n = 6
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Discussion
This study identifies impaired microprocessor processing of
miR-183/96/182 as an important pathogenic mechanism of
age-related memory decline and cognitive dysfunction in neu-
rodegenerative disorders with TDP-43 and FUS pathological
aggregation. While confirming a previously speculated role
for PP1 and miRNAs in age-related memory disorders, the
data newly demonstrate a mechanistic link between PP1,
miR-183/96/182, TDP-43, and FUS.
The activity of nuclear PP1 in the brain may increase with
aging due to an increase in the nuclear isoform of PP1, PP1γ,
or to alterations in the mechanisms of PP1 regulation, e.g., by
sub-cellular targeting, or control of substrate specificity or
phosphatase domains activity [30]. We observed that the
PP1 inhibitor PP1R1A is decreased whereas the PP1 nuclear
scaffolding partner AKAP1 is increased in the hippocampus
of aged mice, possibly explaining the increased activity of
nuclear PP1 with aging. Further, TDP-43 knock-down also
increased nuclear PP1, consistent with a previously demon-
strated regulation of a closely related phosphatase PP2A by
TDP-43 [33]. However, the increase in nuclear PP1 activity
due to TDP-43 knock-down seems to involve a mechanism
different from that of aging. Analysis of samples from cortex
of ALS and FTLD patients with TDP-43 pathology revealed
an increase in the mRNA of PP1γ, a predominantly nuclear
PP1 isoform. This increase could reflect changes in the nucle-
ar spliceosomal machinery, which includes TDP-43 as an in-
tegral component [8].
The results also show that aging and a decrease in TDP-43
and FUS impair the microprocessor-mediated biogenesis of
miR-183/96/182. Although the biogenesis of a number of
neuronal miRNAs is regulated by neuronal activity [43], these
results suggest that aging can impair activity-dependent regu-
lation of miRNAs through an increase in PP1. Similarly, they
newly add miR-183/96/182 to the list of miRNAs regulated
by TDP-43 and FUS. Previous reports have shown that TDP-
43 can regulate microprocessor activity by stabilizing Drosha
or through binding to certain pri-mirs (pri-mir-132, pri-mir-
143, pri-mir-558, pri-mir-574) leading to their differential reg-
ulation by the microprocessor [9, 20]. Interestingly, two of
these miRNAs; miR-132 and miR-574 are also implicated in
Fig. 3 TDP-43 and FUD regulate miR-183/182 biogenesis. a TDP-43
knock-down decreases microprocessor processing of pri-mir-183 and pri-
mir-182 expressed as increased firefly/renilla luminescence (unpaired t
test: pri-mir-183: *p < 0.05; pri-mir-182: *p < 0.05) in mouse N2a cells.
Negative control siRNA, n = 4 and TDP-43 siRNA, n = 4. b Decreased
microprocessor processing of pri-mir-183 on TDP-43 knock-down is
reversed by 20 nM (inhibits PP1/PP2A) but not 0.1 nM okadaic acid
(inhibits PP2A) (one-way ANOVA: F 3, 10 = 27.55, p < 0.0001, post-
hoc: siRNA TDP-43 *p < 0.05, siRNA TDP-43+ 20 nM Okadaic acid
****p < 0.0001). Negative control siRNA, n = 4; TDP-43 siRNA, n = 3;
TDP-43 siRNA + 0.1 nM okadaic acid, n = 3; and TDP-43 siRNA +
20 nM okadaic acid, n = 4. c Nuclear PP1 activity is increased in mouse
N2a cells treated with TDP-43 siRNA compared to control siRNA (un-
paired t test, *p < 0.05). Negative control siRNA, n = 4 and TDP-43
siRNA, n = 4. d FUS knock-down decreases microprocessor processing
of pri-mir-183 and pri-mir-182 expressed as increased firefly/renilla lu-
minescence (unpaired t test: pri-mir-183: **p < 0.01; pri-mir-182: **p <
0.01) in mouse N2a cells. Negative control siRNA, n = 4 and TDP-43
siRNA, n = 4
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the regulation of cognitive processes in the brain [43].
Similarly, FUS has been previously shown to regulate the
biogenesis of a sub-set of miRNAs, notably miR-9, miR-
125, and miR-132 by modulating Drosha recruitment [29].
The simultaneous regulation of miR-183/96/182 and another
miRNA critical for memory formation, miR-132, by TDP-43
and FUS suggests a functional homology between the two
proteins for controlling memory formation by miRNAs.
The results further reveal R-SMADs as potential interme-
diates in the effect of PP1 on the microprocessor. SMAD
proteins are downstream signaling molecules of TGF-β and
bone morphogenic protein (BMP), which translocate to the
nucleus upon activity-induced phosphorylation. Regulation
of the microprocessor by R-SMADs involves a
phosphorylation-dependent interaction with the microproces-
sor accessory protein p68 [1, 6, 7]. Control of nuclear
SMAD1/5 phosphorylation by PP1, combined with the
known role of R-SMADs in selectively regulating the micro-
processor processing, makes them a likely mediator of the
selective regulation of miR-183/96/182 by nuclear PP1. This
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Fig. 4 miR-183/96/182 is altered in the brain of ALS patients with TDP-
43 pathology. a Immunohistochemistry and immunofluorescence of
phosphorylated TDP-43 and pan TDP-43 in patients with sporadic ALS
and age-matched control subjects. a–d Sections of the motor cortex of
controls (a, c) and patients with sporadic ALS (b, d) immunolabeled with
antibody against phosphorylated TDP-43 (a, b), and pan TDP-43 (c, d).
e–f Sections of the same regions labeled with phosphorylated TDP-43-
specific antibody in immunofluorescence (pS403/404). Phosphorylated
TDP-43 was not detected in control (a, e), and physiological TDP-43
shows clear nuclear immunoreactivity (c, adjacent magnification). In ad-
dition to normal TDP-43 staining, pTDP-positive cytoplasmic inclusions
are detected in patients with sporadic ALS (b, f). Filled arrowheads indi-
cate large skein-like inclusions in the cytoplasm and processes of pyra-
midal neurons (adjacent magnification). Empty arrowheads show small
dense inclusions adjacent to nuclei (b, d, f). Note the absence of nuclear
TDP-43 staining in cells with inclusions (d, adjacent magnification). b
miR-183, miR-96, and miR-182 expression is decreased but not of
a control miRNA miR-10b, in cortical tissue from patients with ALS
compared to age-matched controls (unpaired t test: miR-183: ***p <
0.001; miR-96: ***p < 0.001; miR-182: ***p < 0.001; miR-10b p =
0.389). Controls, n = 8 and ALS, n = 10. c PP1γ expression is increased
in cortical tissue from patients with ALS compared to age-matched con-
trols (unpaired t test, *p < 0.05). Controls, n = 8 and ALS, n = 10. d
Expression of targets of miR-183/96/182 is increased in cortical tissue
from patients with ALS compared to age-matched controls (unpaired t
test: HDAC9: *p < 0.05; GRM: *p < 0.05; GRIA: #p < 0.1). Controls, n =
8 and ALS, n = 10
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possibility was investigated in several ways: (1) bio-
informatic validation of the presence of SMAD binding ele-
ment on pri-mir-183/96/182 (data not shown), (2) decreased
pre-mir-183 upon inhibition of TGF-β, (3) selective effect of
SMAD5 on microprocessor processing of pri-mir-183, (4) al-
tered expression of miR-21, a SMAD-dependent miRNA, in
N2a cells after PP1manipulation (data not shown), and finally
(5) decreased phospho-SMAD1/5 in human ALS/FTLD sam-
ples with increased PP1γ and decreased miR-183/96/182.
Virus-mediated overexpression of pre-miR-183/96/182 in
hippocampus reversed age-related cognitive decline in this
study. Such correction establishes that the association between
miR-183/96/182 and age-related cognitive impairment in-
volves suppressed microprocessor-mediated biogenesis of
these miRNAs by increased nuclear PP1, and that cognitive
defects can be corrected if precursor miRNAs are replenished
even when nuclear PP1 is increased. Similarly, EE, known to
improve memory in aged rodents, increased post-
transcriptional biogenesis of miR-183/96/182 and decreased
nuclear PP1 activity in our study. A role for PP1 in age-related
memory loss is also supported by the fact that aged rodents
generally do not showmemory deficits when trained on strong
NOR protocols involving spaced learning [34], an effect
shown to be associated with inhibition of nuclear PP1 [12].
These results highlight the potential of PP1- and miR-183/96/
182-based modalities to delay dementia in the elderly. Indeed,
multi-modal stimulation, an extrapolated equivalent of EE in
humans, has shown promising results in reducing dementia
symptoms in elderly with AD and minimal cognitive impair-
ment [5, 26].
Finally, our results newly highlight a PP1-dependent mech-
anism for the regulation of miRNA biogenesis by TDP-43, a
function that adds to its previously known action on Drosha
and Dicer. This effect on miR-183/96/182 biogenesis could
potentially be responsible for cognitive dysfunctions observed
in TDP-43 pathologies. It may also be involved in motor dys-
functions observed in ALS since miR-183 and miR-182 have
been suggested to play important roles in regulating muscular
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Fig. 5 miR-183/96/182 is altered in the brain of FTLD patients with
TDP-43 pathology. a miR-183, miR-96, and miR-182 expression is de-
creased, but not of a control miRNA miR-10b, in cortical tissue collected
from patients with FTLD compared to age-matched controls (unpaired t
test: miR-183: *p < 0.05; miR-96: *p < 0.05; miR-182: ****p < 0.0001;
miR-10b p = 0.737). Controls, n = 6 and FTLD, n = 12. b PP1γ expres-
sion is increased in cortical tissue collected from patients with FTLD
compared to age-matched controls (unpaired t test, *p < 0.05). Controls,
n = 6 and FTLD, n = 12. c Expression of targets of miR-183/96/182 is
increased compared to age-matched controls in cortical tissue collected
from patients with FTLD (unpaired t test: HDAC9: #p < 0.1; GRM: *p <
0.05; GRIA: *p < 0.1). Controls, n = 6 and FTLD, n = 12. d p-SMAD
expression is decreased compared to age-matched controls in cortical
tissue collected from patients with FTLD (unpaired t test, #p < 0.1).
Controls, n = 5 and FTLD, n = 9
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gene expression in animal models of pathological muscle at-
rophy [17, 24].
Emerging evidence suggests that besides neuronal death,
epigenetic mechanisms are responsible for early and persistent
synaptic dysfunction and cognitive decline in the
neurodegenerating brain. These epigenetic changes include
increased expression and activity of HDACs [13]. Our results
suggest that impaired biogenesis of memory-promoting
miRNAs could be an additional non-genomic mechanism of
cognitive impairment in neurodegenerative disorders. Future
studies should consider a role for impaired biogenesis of ad-
ditional miRNAs known to regulate memory formation, such
as miR-132/212 [15], miR-335 [4], miR-12 [28], miR-124
[28], miR-181a [44], and miR-29b [21] in neurodegenerative
disorders. Furthermore, cognitive alterations observed in ALS
are pleiotropic with pronounced frontal-mediated behavioral
dysfunctions in a vast majority of patients [41] and surprising-
ly low rates of depression despite physical disability [35].
Evidence suggesting a role for miR-183/96/182 in the regula-
tion of other cognitive functions, such as stress response [27]
and pro-depressive behavior [25] in mice suggests their po-
tential contribution to broader cognitive phenotype of ALS,
which warrants further investigations. In conclusion, we have
identified a novel role for impaired microprocessor-mediated
miRNA biogenesis that occurs downstream of several aging
and neurodegeneration-related pathways in memory disor-
ders, and may have important implications for prevention
and/or treatment of dementia.
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